Stoke Therapeutics Inc (STOK)

CapEx to Revenue

21.19%

Quarterly · Period ending:

STOK logo

STOK CapEx to Revenue

Latest reported21.19%
STOK Quarterly CapEx/Revenue (0.00% → 21.19%)
High-resolution chart · PNG

STOK capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
21.1903%
5.667%
16.5478%
1.2415%
1.1146%
0.0959%
0.1857%
2.1046%
0.9522%
0.2846%
8.1727%
11.578%
-33.817%
3.2026%
12.5115%
69.8795%
21.108%
28.0333%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.